Hospital Leaders Explore the Future of Insulin Management at Glytec’s Conference on Glycemic Innovation and Collaboration

Annual Conference to Fuel Continued Momentum in Journey to Improve Inpatient Glycemic Management and Patient Safety WALTHAM, Mass. (July 26, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced details about its annual conference on glycemic management and collaboration, “Time To Target: The Future of Glycemic Management.”...
Read More

National Quality Initiatives Amplify Health Systems’ Focus on Effective Glycemic Management as Glytec Fortifies Industry Leadership Position

Strategic Partnerships, Product Innovation and Customer Expansion Underpin Insulin Dosing Technology Company’s Sustained Growth WALTHAM, Mass. (March 15, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced that it has significantly expanded the deployment of its eGlycemic Management System® (eGMS) over the past 12 months to...
Read More

Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management

Leader in Endocrinology Research Implements eGlycemic Management System Across Hospitals, Dedicates Resources Towards Research and Development WALTHAM, Mass. (January 25, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a new strategic partnership with Nebraska Medicine to advance patient safety and innovation around...
Read More

Glytec and Roche Announce Strategic Partnership to Bring Digital Health Innovation in Glycemic Decision Support to the Hospital Bedside

As CMS Creates an Emphasis on Hyperglycemia and Hypoglycemia Rates in the Hospital, Partnership Aims to Transform the Standard of Care WALTHAM, MASS. (January 12, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a strategic partnership with Roche Diagnostics USA, a division of the world’s largest biotech company and a...
Read More

Glytec Achieves HITRUST CSF® Certification to Manage Risk, Improve Security Posture and Meet Compliance Requirements

HITRUST CSF Certification validates Glytec is committed to meeting key regulations and protecting sensitive information. WALTHAM, MASS. (January 4, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced that Glytec’s eGlycemic Management System®, including Glucommander™, has achieved Certified status for information security by...
Read More

Glytec Awarded First Patient Safety Solutions Agreement with Premier

Glytec named sole supplier of insulin management software for Premier’s network of more than 4,400 U.S. hospitals and 225,000 providers WALTHAM, MASS. (October 26, 2021) –Glytec – the only provider of cloud-based insulin management software across the continuum of care, today announced that it has been awarded a group purchasing agreement with Premier and will be the organization’s sole...
Read More

Healthcare Industry Leaders Unite Around Patient Safety at Glytec’s Inaugural Conference on Glycemic Innovation and Collaboration

Conference Identifies Key Strategies and Actionable Insights for Hospitals to Optimize Glycemic Management Ahead of New CMS Core Measures WALTHAM, MASS. (August 31, 2021) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today revealed details about its inaugural conference on glycemic innovation and collaboration, “Time to Target: Uniting...
Read More

Glytec Appoints Dr. Jordan Messler as Chief Medical Officer

Experienced Physician and Glycemic Expert to Drive Safe Clinical Best Practices as Company Scales to Hospitals across the Country WALTHAM, MASS. (July 13, 2021) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced the appointment of Jordan Messler, MD, SFHM, FACP to Chief Medical Officer. In this new role, Dr. Messler will be...
Read More

Glytec Research Presented at American Diabetes Association’s 81st Scientific Sessions Shows Low Hypoglycemia for Adults with T1D Treated with eGlycemic Management System

Largest study to analyze T1D Patients With and Without DKA finds Glucommander insulin management software can safely keep blood glucose levels in range WALTHAM, MASS. (June 22, 2021) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today published the largest descriptive analysis of adult T1D patients with and without Diabetic ketoacidosis...
Read More

Dr. Bruce Bode Looks Back and Forward at Automated Glucose Control Systems in Hospital Settings at ATTD20

Close Concerns and diaTribe covered Glytec co-founder Dr. Bruce Bode’s presentation ATTD 2020 (Advanced Technologies & Treatments for Diabetes) as he explored the past, present and future of automated glucose control systems in hospital settings Dr. Bruce Bode summarized decades of experience in delivering automated glucose control in the hospital setting. As background, Dr. Bode co-founded...
Read More